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Abstract: This study was designed to
evaulate the effects of reconstruction of
anterior cruciate ligament on cartilage
collagen and proteoglycan metabolism.
Proteoglycan fragments (PF) and matrix
metalloproteinase-1 (MMP-1) levels were
assessed in synovial fluids aspirated from 17
patients preoperatively and at 1st month
postoperatively. Synovial fluids of 10 healthy
knee served as controls. Both MMP-1 and
proteoglycan fragments were found
significantly elevated in pathological knees
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Introduction
Homeostasis of articular cartilage in a healthy joint is
influenced by several factors such as injury, synovitis,
bleeding etc (1-4). Biochemical markers in synovial fluid
have been shown to be elevated after injury involving ACL
ligament (4, 5). In a recent study, Taşkıran et al. have
clarified that proteoglycan metabolism is effected by
surgical trauma and homeostasis of proteoglycan
metabolism could not be provided until the end of 12th
month with respect to control values (3). In our
knowledge, affections of other components of articular
cartilage such as collagen after surgical trauma has not
been studied yet.

preoperatively with compare to control. The
postoperative levels of MMP-1 and
proteoglycans were also significantly higher
than preoperative and control values. These
findings suggest that surgical trauma may
have detrimental effects on cartilage matrix
metabolism through increasing degradation
of proteoglycan and collagen.
Key
Words:
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matrix
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to yield characteristic 1-quarter-3-quarter products. The
major secreted form of collagenase is a latent proenzyme
of Mr 51, 929, which can be N-glycosylated to a minor
form Mr 57,000. Procollagenase can be activated at least
in vitro, by proteinases and mercurials (6, 9).
In the present study, we aim to demonstrate the
effects of surgical trauma on degradative enzyme activity
and the correlation between proteoglycan and collagen
degradation in articular cartilage.
Material and Methods
Patients: Thirty anterior cruciate ligament (ACL)
reconstructed knees comprised the study group. Average
age was 27 (range: 18 to 42) and male to female ratio
was 20:10. Synovial samples were obtained
preoperatively and at the end of first month
postoperatively. While proteoglycan fragments were
measured in all samples (n=30), MMP-1 activity was
measured only in randomly selected 17 knees of 30.

A main role in cartilage matrix degradation has been
suggested
for
the
metalloproteinase
family.
Metalloproteinases, such as collagenase and stromelysin,
are produced by chondrocytes and synovial fibroblasts
and considered to play a major role in the proteolytic
degradation of extracellular matrix in joint and skeletal
diseases. These enzymes are secreted in a proenzyme
form and the destruction of articular cartilage is thought
to be the result of the action of these potent enzymes (68).

Controls: Ten asymptomatic opposite knees of any
patient who underwent arthroscopic surgery rather than
ACL reconstruction consisted of control group.

Collagenase (EC 3.4.24.7, matrix metalloproteinase-1
(MMP-1)) cleaves the collagen triple helix at a single locus

Collection of synovial fluid: Informed consent was
obtained from all patients prior to investigation. Synovial
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Figure 1.

Proteoglycan fragments (µg/ml).
Bars represent mean value±SD.* different from control (p<0.01), **different from preoperative values
(p<0.05).

Figure 2.

MMP-1 levels (ng/ml).
Bars represent mean value±SD.*different from control (p<0.05), **different from preoperative values
(p<0.05).
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fluid samples were aspirated preoperatively and at 1st
month postoperatively. Aspiration procedure was
performed in the operating room under sterile
conditions. Firstly, 20 ml of physiological serum was
injected into the knee joint in all cases. Then, twenty
cycles of passive motion were applied prior to aspiration.
Synovial fluids were centrifuged to remove the cells and
debris and the supernatants were stored at -30˚C until
the assay.
Proteoglycan assay: Cartilage breakdown was
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determined by the amount of proteoglycans released into
knee joint and proteoglycan fragments were measured
using dimethylmethylene blue (DMMB) assay (10). Before
the assay, aliquots of synovial (500 µl) were added to 500
µl 20 mM of sodium phosphate buffer (pH 6.8)
containing 1 mM EDTA, 2 mM dithiothreitol, 4 mM Nacetylcysteine and 150 µg papain. All samples were then
mixed and incubated for two hours at 65˚C. Digestion
was stopped adding 10 mM of iodoacetic acid and then
250 µl of the sample was mixed with dimethylmethylene
blue as described previously (10). The assay was
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calibrated with shark chondroitin sulphate and suitable
blanks. It was found to be linear from 2.5 to 50 µgr/ml.
Results were given mean values obtained from three
assays.
Collagenase (MMP-1) assay: Collagenase was
assayed using double-antibody sandwich ELISA kit which
is commercially available from Amersham™. The synovial
fluids were diluted 1:10 and 1:20 and assays were
performed at 1:10 dilutions when levels wereoo low to
measure at 1:20 and assays were performed at 1:10
dilutions when levels were too low to measure 1:20
dilution. The standard curve was obtained between the
6,25-100 ng/ml.
Statistical analysis: To find the statistically
differences between control, preoperative and
postoperative values Wilcoxon matched paired test was
performed. Spearsman’s correlation test was used to
evaluate the correlation between PF and MMP-1 levels.
All data were expressed as means±SD and the limit of
statistical significance was set up at p<0.05.
Results
MMP-1 levels were significantly higher in pathological
knees (234.73±178.07 ng/ml) preoperatively than those
in controls (69.41±41.73 ng/ml, p<0.05). MMP-1 level
at the end of the first month (685.18±487.97 ng/ml)
was significantly different when it was compared with
preoperative values (p<0.05) and control values
(p<0.01) (Figure 1).
Proteoglycan fragment levels were found significantly
higher in pathological knees (38.55±13.05 µg/ml)
preoperatively with respect to controls (18.26±7.33
µg/ml, p<0.01) and the values obtained at 1st month
were significantly higher than control (p<0.01) and
preoperative values similar to MMP-1 levels
(65.83±19.74 µg/ml, p<0.05), (Figure 2).
There was no significant correlation between the pre
and postoperative PF and MMP-1 levels (r=0.449,
p=0.062).
Discussion
Matrix metalloproteinases are critical in maintaining
the proper biochemical composition and physical
characteristics of all tissues particularly in cartilage
matrix. At the transcriptional level, MMP expression is
precisely controlled by various cytokines acting through
positive or negative regulatory elements of its genes (11).
Moreover, MMP activity is post-transcriptionally

regulated by proteolytic activation of the latent
proenzymes and by interaction with specific tissue
inhibitors of metalloproteinases (TMPs) (12). Under
normal physiological conditions, constitutive expression
of the MMPs is low. However, under pathologic
conditions such as inflammation, injury, osteoarthritis,
rheumatoid arthritis MMP expression in cartilage is
disregulated (13, 14).
Recently, Lohmander et al. have indicated increased
levels of proteoglycan fragments, stromelysin-1 and
collagenase in knee synovial fluids of ACL or meniscus
injured patients (15). In our study, preoperative levels of
MMP-1 and PF levels showed similar pattern and they
were found significantly higher in preoperative knees
than the normal knees. The proteolytic breakdown of the
matrix molecules seems to be due to a change in
biomechanics of the injured knee.
In the present study, both postoperative PF and MMP1 levels were found elevated with respect to preoperative
values. These findings reflect some significant changes in
the collagen and proteoglycan metabolism after the
surgery. It is possible to say hemarthrosis, and joint
debridement may have some activational effects on
cartilage catabolism during the surgery. Furthermore,
since synovium is one of the tissues which produce
proteinases, synovial changes after ACL reconstruction
(16) may cause activation of metalloproteinases and
degradation of proteoglycans and collagen.
Although levels of PF and MMP-1 were found
elevated pre and postoperatively, there was no significant
correlation between them. In accordance with this data,
Wolfe et al. have demonstrated that the regulation of
collagenase is distinct from stromelysin which is mainly
responsible for proteoglycan degradation and these two
metalloproteinases have different roles in normal and
abnormal cartilage (14). In a recent study, Kozaci et al.
have showed a correlation between the MMP activity and
type II collagen, but not proteoglycan, in cartilage
cultures (17). These observations reveal that collagen and
proteoglycan have different rate of metabolism during
cartilage matrix turnover in normal and disease.
In an injury model, La Fleur et al. investigated the
roles of matrix metalloproteinases and TIMP-1 and
observed both of MMPs and their inhibitors were induced
after tissue injury and expression of mRNAs of MMPs and
TIMP-1 were regulated by cytokines in vivo (18). In
another study, Moses et al. assessed the involvement of
MMPs and their inhibitors in normal wound healing by
measuring MMP-1, MMP-2 and MMP-9. They detected
the presence of MMP-1 in the wound fluid during days 1-
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6 after wounding and the time course activity of matrix
metalloproteinase inhibitors (19). These findings clearly
indicate that MMPs can be activated during the injury and
both MMPs and their inhibitors have importance in
remodelling of extracellular matrix.

From our data we can conclude that surgical trauma
has some detrimental effects on the articular cartilage
and it is probably due to action of metalloproteinases. Our
results may provide very important clues about the
postoperative status of cartilage but more detailed
experimental studies are required.
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